Tivorsan Pharmaceuticals, Inc. today announced that Justin Fallon, PhD – Corporate Director, Founding Scientist and Brown University Professor – will present at next week’s Biotech Showcase™ 2015 in San Francisco, CA. Dr. Fallon will provide a company overview as well as the scientific rationale behind recombinant biglycan (TVN-102) as a disease-modifying treatment candidate for Duchenne Muscular Dystrophy and other progressive neuromuscular disorders.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
